Edition:
United States

Deena Beasley

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

Dec 11 2017

Merck raises stakes in lung cancer as rivals close in

LOS ANGELES Merck & Co Inc, maker of the only immunotherapy approved for patients newly-diagnosed with the most common type of lung cancer, could solidify its lead by playing the long game, even as rivals edge closer.

Dec 11 2017

Merck raises stakes in lung cancer as rivals close in

LOS ANGELES Merck & Co Inc, maker of the only immunotherapy approved for patients newly-diagnosed with the most common type of lung cancer, could solidify its lead by playing the long game, even as rivals edge closer.

Dec 10 2017

Gilead's new drug keeps 56 percent of lymphoma trial patients alive

More than half of trial patients with an advanced, aggressive form of blood cancer lived for at least a year after one-time treatment with Yescarta, a novel therapy sold by Gilead Sciences Inc, according to study results presented on Sunday.

Nov 16 2017

Trump administration proposes Medicare rules aimed at opioids, drug costs

The Trump administration on Thursday proposed changes to Medicare drug plans including limits on opioid prescriptions and rules aimed at reducing drug costs for seniors, such as requiring health insurers to pass on discounts to consumers.

Nov 13 2017

New blood pressure range means half of Americans have hypertension

Tighter blood pressure guidelines from U.S. heart organizations mean millions more people need to make lifestyle changes, or start taking medication, in order to avoid cardiovascular problems.

Nov 13 2017

New blood pressure range means nearly half of Americans have hypertension

Nov 13 Tighter blood pressure guidelines from U.S. heart organizations mean millions more people need to make lifestyle changes, or start taking medication, in order to avoid cardiovascular problems.

Oct 26 2017

Gilead weak hepatitis C sales outlook sends shares lower

Gilead Sciences Inc posted better-than-expected third-quarter profit on Thursday, but shares fell after hours as use of its flagship hepatitis C drugs waned further and the company said it expects to feel the full impact of more competition in the current quarter.

Oct 26 2017

Gilead 3rd-quarter profit falls, but beats Wall Street estimates

Oct 26 Gilead Sciences Inc reported lower third-quarter profits on Thursday as use of its flagship hepatitis C drugs continued to wane, but the results beat Wall Street estimates due to lower costs.

Oct 26 2017

Bristol-Myers sales in line, but profit margins worsen

Bristol-Myers Squibb Co reported a 7 percent increase in third-quarter revenue as sales of key drugs met Wall Street expectations, but earnings fell short due to higher costs and an inventory write-off, sending shares down 4 percent.

Oct 26 2017

Bristol Myers posts in-line sales, but profit margins worsen

Oct 26 Bristol-Myers Squibb Co reported a 7 percent increase in third-quarter revenue as sales of key drugs met Wall Street expectations, but adjusted earnings fell slightly short due to an inventory write-off.

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary